Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell
Topical drug delivery against cutaneous leishmaniasis (CL) signifies an effective alternate for improving the availability and reducing the toxicity associated with the parenteral administration of conventional sodium stibogluconate (SSG) injection. The basic aim of the study was to develop nano-def...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2018.1494222 |
_version_ | 1818967501899300864 |
---|---|
author | M. Junaid Dar Fakhar Ud Din Gul Majid Khan |
author_facet | M. Junaid Dar Fakhar Ud Din Gul Majid Khan |
author_sort | M. Junaid Dar |
collection | DOAJ |
description | Topical drug delivery against cutaneous leishmaniasis (CL) signifies an effective alternate for improving the availability and reducing the toxicity associated with the parenteral administration of conventional sodium stibogluconate (SSG) injection. The basic aim of the study was to develop nano-deformable liposomes (NDLs) for the dermal delivery of SSG against CL. NDLs were formulated by a modified thin film hydration method and optimized via Box–Behnken statistical design. The physicochemical properties of SSG-NDLs were established in terms of vesicle size (195.1 nm), polydispersity index (0.158), zeta potential (−32.8 mV), and entrapment efficiency (35.26%). Moreover, deformability index, in vitro release, and macrophage uptake studies were also accomplished. SSG-NDLs were entrapped within Carbopol gel network for the ease of skin application. The ex vivo skin permeation study revealed that SSG-NDLs gel provided 10-fold higher skin retention towards the deeper skin layers, attained without use of classical permeation enhancers. Moreover, in vivo skin irritation and histopathological studies verified safety of the topically applied formulation. Interestingly, the cytotoxic potential of SSG-NDLs (1.3 mg/ml) was higher than plain SSG (1.65 mg/ml). The anti-leishmanial activity on intramacrophage amastigote model of Leishmania tropica showed that IC50 value of the SSG-NDLs was ∼ fourfold lower than the plain drug solution with marked increase in the selectivity index. The in vivo results displayed higher anti-leishmanial activity by efficiently healing lesion and successfully reducing parasite burden. Concisely, the outcomes indicated that the targeted delivery of SSG could be accomplished by using topically applied NDLs for the effective treatment of CL. |
first_indexed | 2024-12-20T13:49:48Z |
format | Article |
id | doaj.art-104d9edd6479458cbd8c47738bf9c321 |
institution | Directory Open Access Journal |
issn | 1071-7544 1521-0464 |
language | English |
last_indexed | 2024-12-20T13:49:48Z |
publishDate | 2018-01-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Drug Delivery |
spelling | doaj.art-104d9edd6479458cbd8c47738bf9c3212022-12-21T19:38:33ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642018-01-012511595160610.1080/10717544.2018.14942221494222Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cellM. Junaid Dar0Fakhar Ud Din1Gul Majid Khan2Quaid-i-Azam UniversityQuaid-i-Azam UniversityQuaid-i-Azam UniversityTopical drug delivery against cutaneous leishmaniasis (CL) signifies an effective alternate for improving the availability and reducing the toxicity associated with the parenteral administration of conventional sodium stibogluconate (SSG) injection. The basic aim of the study was to develop nano-deformable liposomes (NDLs) for the dermal delivery of SSG against CL. NDLs were formulated by a modified thin film hydration method and optimized via Box–Behnken statistical design. The physicochemical properties of SSG-NDLs were established in terms of vesicle size (195.1 nm), polydispersity index (0.158), zeta potential (−32.8 mV), and entrapment efficiency (35.26%). Moreover, deformability index, in vitro release, and macrophage uptake studies were also accomplished. SSG-NDLs were entrapped within Carbopol gel network for the ease of skin application. The ex vivo skin permeation study revealed that SSG-NDLs gel provided 10-fold higher skin retention towards the deeper skin layers, attained without use of classical permeation enhancers. Moreover, in vivo skin irritation and histopathological studies verified safety of the topically applied formulation. Interestingly, the cytotoxic potential of SSG-NDLs (1.3 mg/ml) was higher than plain SSG (1.65 mg/ml). The anti-leishmanial activity on intramacrophage amastigote model of Leishmania tropica showed that IC50 value of the SSG-NDLs was ∼ fourfold lower than the plain drug solution with marked increase in the selectivity index. The in vivo results displayed higher anti-leishmanial activity by efficiently healing lesion and successfully reducing parasite burden. Concisely, the outcomes indicated that the targeted delivery of SSG could be accomplished by using topically applied NDLs for the effective treatment of CL.http://dx.doi.org/10.1080/10717544.2018.1494222cutaneous leishmaniasissodium stibogluconatetransfersomesnano-deformable liposomesmacrophage uptake |
spellingShingle | M. Junaid Dar Fakhar Ud Din Gul Majid Khan Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell Drug Delivery cutaneous leishmaniasis sodium stibogluconate transfersomes nano-deformable liposomes macrophage uptake |
title | Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell |
title_full | Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell |
title_fullStr | Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell |
title_full_unstemmed | Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell |
title_short | Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell |
title_sort | sodium stibogluconate loaded nano deformable liposomes for topical treatment of leishmaniasis macrophage as a target cell |
topic | cutaneous leishmaniasis sodium stibogluconate transfersomes nano-deformable liposomes macrophage uptake |
url | http://dx.doi.org/10.1080/10717544.2018.1494222 |
work_keys_str_mv | AT mjunaiddar sodiumstibogluconateloadednanodeformableliposomesfortopicaltreatmentofleishmaniasismacrophageasatargetcell AT fakharuddin sodiumstibogluconateloadednanodeformableliposomesfortopicaltreatmentofleishmaniasismacrophageasatargetcell AT gulmajidkhan sodiumstibogluconateloadednanodeformableliposomesfortopicaltreatmentofleishmaniasismacrophageasatargetcell |